推薦產品
等級
pharmaceutical primary standard
API 家族
resveratrol
製造商／商標名
EDQM
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
−20°C
SMILES 字串
Oc1ccc(cc1)\C=C\c2cc(O)cc(O)c2
InChI
1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
InChI 密鑰
LUKBXSAWLPMMSZ-OWOJBTEDSA-N
尋找類似的產品？ 前往 產品比較指南
訊號詞
Warning
危險聲明
危險分類
Eye Irrit. 2
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
>392.0 °F - closed cup - (External MSDS)
閃點（°C）
> 200.0 °C - closed cup - (External MSDS)
客戶也查看了
Alexandra Maier-Salamon et al.
Annals of the New York Academy of Sciences, 1290, 98-106 (2013-07-17)
Resveratrol exhibits a variety of biological and pharmacological activities despite its extensive metabolism to sulfates and glucuronides in the intestine and liver. The metabolism of resveratrol is cell specific and strongly correlates with enzyme expression levels. However, a high rate
Agneta Oskarsson et al.
The Prostate, 74(8), 839-851 (2014-03-13)
Resveratrol (RSV) and resveratrol analogs have a potential use in prostate cancer chemoprevention due to effects on for example, cell growth, apoptosis, angiogenesis, and metastasis. However, inhibition of CYP17A1, a key enzyme in the androgen biosynthesis and a target for
Mary Ann Augustin et al.
Annals of the New York Academy of Sciences, 1290, 107-112 (2013-07-17)
There has been interest in the use of trans-resveratrol as a natural preventative agent for improving health and alleviating a range of diseases. However, resveratrol has low bioavailability, and this has been associated with its poor water solubility, its low
Morten Møller Poulsen et al.
Annals of the New York Academy of Sciences, 1290, 74-82 (2013-07-17)
In the search for novel preventive and therapeutic modalities in the management of metabolic diseases and obesity, resveratrol has attracted great attention over the past decades. Preclinical trials suggest that resveratrol mimics the metabolic effects of calorie restriction (CR) via
Silvie Timmers et al.
Annals of the New York Academy of Sciences, 1290, 83-89 (2013-07-17)
The number of people suffering from metabolic disorders is dramatically increasing worldwide. The need for new therapeutic strategies to combat this growing epidemic of metabolic diseases is therefore also increasing. In 2003, resveratrol was discovered to be a small molecule
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務